Detalhe da pesquisa
1.
A Phase I study of the safety, pharmacokinetics and efficacy of navitoclax plus docetaxel in patients with advanced solid tumors.
Future Oncol
; 17(21): 2747-2758, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-33849298
2.
Hyperglycemia and Phosphatidylinositol 3-Kinase/Protein Kinase B/Mammalian Target of Rapamycin (PI3K/AKT/mTOR) Inhibitors in Phase I Trials: Incidence, Predictive Factors, and Management.
Oncologist
; 21(7): 855-60, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27151652
3.
Targeting the PI3K-AKT-mTOR signaling network in cancer.
Chin J Cancer
; 32(5): 253-65, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23642907
4.
miR-31-3p Expression and Benefit from Anti-EGFR Inhibitors in Metastatic Colorectal Cancer Patients Enrolled in the Prospective Phase II PROSPECT-C Trial.
Clin Cancer Res
; 25(13): 3830-3838, 2019 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30952636
5.
Longitudinal Liquid Biopsy and Mathematical Modeling of Clonal Evolution Forecast Time to Treatment Failure in the PROSPECT-C Phase II Colorectal Cancer Clinical Trial.
Cancer Discov
; 8(10): 1270-1285, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30166348
6.
Assessment of fertility control efforts in a selected area of Karachi, Pakistan.
Ulster Med J
; 76(3): 144-5, 2007 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-17853640
7.
Cancer therapeutics: Targeting the apoptotic pathway.
Crit Rev Oncol Hematol
; 90(3): 200-19, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24507955
8.
Reversible posterior leukoencephalopathy syndrome following sunitinib therapy: a case report and review of the literature.
Tumori
; 98(5): 139e-142e, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-23235770
9.
Metastatic melanoma: a regional review and future directions.
Tumori
; 98(5): 575-80, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-23235751